PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
56.59%
Revenue growth similar to AR's 60.63%. Walter Schloss would see if both companies share industry tailwinds.
169.31%
Gross profit growth similar to AR's 157.41%. Walter Schloss would assume both firms track common industry trends.
346.02%
EBIT growth above 1.5x AR's 174.31%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
346.02%
Operating income growth above 1.5x AR's 174.31%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
93.57%
Net income growth comparable to AR's 94.49%. Walter Schloss might see both following similar market or cost trajectories.
93.61%
EPS growth similar to AR's 94.49%. Walter Schloss would assume both have parallel share structures and profit trends.
93.61%
Similar diluted EPS growth to AR's 94.49%. Walter Schloss might see standard sector or cyclical influences on both firms.
0.03%
Share change of 0.03% while AR is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
No Data
No Data available this quarter, please select a different quarter.
-0.03%
Dividend reduction while AR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-37.22%
Negative OCF growth while AR is at 65.88%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-117.36%
Negative FCF growth while AR is at 36.92%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
50.67%
10Y CAGR of 50.67% while AR is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
-71.91%
Negative 5Y CAGR while AR stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
244.02%
3Y CAGR of 244.02% while AR is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
136.69%
OCF/share CAGR of 136.69% while AR is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-66.16%
Negative 5Y OCF/share CAGR while AR is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-47.37%
Negative 3Y OCF/share CAGR while AR stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-159.62%
Negative 10Y net income/share CAGR while AR is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-107.51%
Negative 5Y net income/share CAGR while AR is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-112.83%
Negative 3Y CAGR while AR is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
24.14%
Equity/share CAGR of 24.14% while AR is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
-74.10%
Negative 5Y equity/share growth while AR is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-67.48%
Negative 3Y equity/share growth while AR is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
908.15%
Dividend/share CAGR of 908.15% while AR is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-0.47%
Negative 5Y dividend/share CAGR while AR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-0.02%
Negative near-term dividend growth while AR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-4.93%
Firm’s AR is declining while AR shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-100.00%
Inventory is declining while AR stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.11%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-4.09%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
22.57%
Debt growth of 22.57% while AR is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
1198.04%
SG&A growth well above AR's 14.76%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.